Press releases

Three-year results and two-year pooled analysis presented at ACC demonstrate continued positive outcomes for both PROMUS® and TAXUS® Stents

Analysis of economic and quality of life outcomes are based on one-year data from landmark SYNTAX trial

Presentations to include additional analyses of one-year data from the landmark SYNTAX study

Upgrade follows the Moody's actions of March 12, when it raised Company's outlook to stable from negative

iCross™ designed to improve the deliverability of Company's market-leading intravascular ultrasound (IVUS) technology

Rating agency notes that Company has been able to retain market share in the DES arena while rebuilding its CRM presence with new product launches

A live webcast of the March 17 conference session will be available.

Legislation to evaluate the current state of chronic pain care will now move to consideration by the full House

Japanese patients now have access to second-generation drug-eluting stent

Joel Fleishman to retire from Board